Clinical Trials Directory

Trials / Unknown

UnknownNCT02781493

Efficacy of Prucalopride Plus Polyethylene Glycol in Bowel Preparation for Colonoscopy

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
600 (estimated)
Sponsor
Shandong University · Academic / Other
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Not accepted

Summary

Prucalopride based bowel cleansing regimen might be helpful to improve bowel cleansing quality before colonoscopy.

Detailed description

Colonoscopy is the standard approach for evaluating the colon currently. Thorough bowel cleansing is critical for adequate visualization of colonic mucosa during colonoscopy. Inadequate bowel cleansing results in adverse consequences for the examination, including lower adenoma detection rates, longer procedural time, lower cecal intubation rates, shorter intervals between examinations and an estimated 12-22% increase in overall colonoscopy cost.Unfortunately, despite advances in bowel preparation methods, up to one-third of all colonoscopies are reported to have an inadequate bowel preparation. Prucalopride can accelerate colonic transit and has been demonstrated to be efficient in constipation.

Conditions

Interventions

TypeNameDescription
DRUG2 mg Prucalopride plus 2 L Polyethylene Glycol regimenPatients enrolled in the Prucalopride group will recieve 2 mg Linaclotide plus 2 L Polyethylene Glycol regimen before colonoscopy.
DRUG2 mg Placebo plus 2 L Polyethylene Glycol regimenPatients enrolled in the Placebo group will recieve 2 mg Placebo plus 2 L Polyethylene Glycol regimen before colonoscopy.

Timeline

Start date
2016-06-01
Primary completion
2017-03-01
Completion
2017-03-01
First posted
2016-05-24
Last updated
2016-05-27

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT02781493. Inclusion in this directory is not an endorsement.